Angiotensin II receptors: cloning and expression

Area of Science:

• Molecular Biology
• Pharmacology
• Biochemistry

Background:

• Angiotensin II receptors (AT1, AT2) play critical roles in cardiovascular and renal functions.
• Understanding the distinct mechanisms of AT1A, AT1B, and AT2 receptor isoforms is essential for targeted therapeutic development.
• Previous difficulties in receptor purification hindered detailed mechanistic studies.

Purpose of the Study:

• To elucidate the distinct mechanisms of action for angiotensin II receptor isoforms (AT1A, AT1B, AT2).
• To overcome challenges associated with receptor purification through expression cloning.
• To characterize the signaling pathways associated with AT1 and AT2 receptors.

Main Methods:

• Expression cloning of AT1A, AT1B, and AT2 receptor cDNAs from bovine and rat sources.
• Isolation of human cDNA and rat/human genomic DNA for receptor analysis.
• Analysis of receptor protein structure and amino acid identity.
• Investigation of G protein coupling and downstream signaling pathways.

Main Results:

• AT1A and AT1B receptors encode 359 amino acid proteins; AT2 encodes a 363 amino acid protein.
• Both AT1 and AT2 receptors exhibit a seven transmembrane domain structure.
• AT1 receptors couple to G proteins, activating phospholipase C, inhibiting adenylyl cyclase, and opening L-type Ca(2+) channels.
• AT2 receptors inhibit phosphotyrosine phosphatase activity via a pertussis-toxin-sensitive mechanism, without affecting guanylyl cyclase.

Conclusions:

• AT1 and AT2 receptors possess distinct structural features and signaling mechanisms.
• AT1 receptors mediate diverse cellular responses through multiple G protein pathways.
• AT2 receptors exert inhibitory effects on phosphotyrosine phosphatase activity, suggesting unique physiological roles.